Our data suggests that we can at least double the patient population benefitting from immunotherapy.
Company Description
Verseau focus is building a pipeline of first-in-class therapies that modulate macrophages to trigger a coordinated immune attack on cancer.
Market
Cancer therapeutics and immune/inflammatory diseases
Location
Bedford,
MA,
USA
Coinvestors
20/20 HealthCare Partners, 3SBio, Alexandria Venture Investments, Highlight Capital, InHarv Partners, The Mark Foundation for Cancer Research, Yonghua Capital